RxDoctor Payments Data

Juliane Johnson

Family · Ellaville, GANPI 1114338761

Payments from drug & device makers

$1,461in general payments, 2019–2025

Across 81 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$310
  • Lilly USA, LLC$176
  • Boehringer Ingelheim$146
  • AbbVie$137
  • Amgen$105
  • AstraZeneca$94
  • plus $494 from 13 others

What the payments were for

  • Food & beverage$1,461100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,461 in reported general payments places this provider in the 70th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$20,431
Medicare patients
137
Services billed
328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide57$82,699
MounjaroTirzepatide32$44,338
JardianceEmpagliflozin31$31,086
LinzessLinaclotide22$16,976
TrulicityDulaglutide13$16,446
FarxigaDapagliflozin Propanediol17$15,081
JanuviaSitagliptin Phosphate18$13,773
EliquisApixaban14$7,106
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,045
SymbicortBudesonide/Formoterol Fumarate13$2,778
Albuterol Sulfate HfaAlbuterol Sulfate84$1,992
Gabapentin106$1,516
SynthroidLevothyroxine Sodium16$1,490
Atorvastatin Calcium128$1,111
Levetiracetam24$1,099

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$310$82,69957 claims
Lilly USA, LLCMounjaro, Trulicity$176$60,78545 claims
Boehringer IngelheimJardiance$146$31,08631 claims
AbbVieLinzess, Synthroid$137$18,46638 claims
AstraZenecaFarxiga, Symbicort$94$17,85930 claims
PfizerEliquis$33$7,10614 claims
GSKTrelegy Ellipta$77$7,04511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,258 family providers in Georgia.

Other family in Ellaville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →